预防消化系统癌症:揭示了Chk2作为潜在治疗点的作用
Yucheng An1, Duolun Gao1, Yanjie He2
1Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
Genes & diseases
|November 11, 2024
概括
检查点激酶2 (Chk2) 在消化系统癌症的发展和治疗耐药性方面发挥着关键作用. 准Chk2为新的消化道癌症疗法提供了一个有前途的战略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 消化系统癌症对健康构成重大风险,瘤发生和治疗耐药性的潜在机制尚不清楚.
- 检查点酶2 (Chk2) 对于细胞循环调节和DNA损伤反应至关重要,使其调节失调成为癌症发展的因素.
研究的目的:
- 审查Chk2在癌症相关的细胞过程中的多方面的作用.
- 探索 Chk2 突变,细胞循环失调和消化系统瘤发生之间的联系.
- 评估Chk2作为克服放射化疗耐药性的潜在治疗标.
主要方法:
- 文献综述综合了关于Chk2功能的当前研究.
- 对Chk2参与DNA损伤反应,细胞循环控制,自和恒常的分析.
- 检查将Chk2与瘤发生和治疗耐药性联系起来的证据.
主要成果:
- Chk2失调和突变与细胞循环异常有关,导致瘤发生.
- Chk2影响DNA修复,细胞循环进展,自和组织平衡.
- 有证据表明,Chk2抑制可以逆转放射化疗耐药性.
结论:
- Chk2是一个关键的调节器,与消化系统癌症的发病和进展有关.
- 向Chk2为增强癌症治疗疗效提供了一个可行的治疗途径.
- 对Chk2机制的进一步研究将揭示消化系统瘤发生,并指导新的治疗策略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K


